Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

Publications
Jun 2026
The Supreme Court Reins in ISP Copyright Liability in Cox Communications v. Sony Music
Key Takeaway: In Cox Communications v. Sony Music, the U.S. Supreme Court unanimously held that an internet service provider (ISP) cannot be held liable for contributory copyright infringement based on...
News
Jun 2026
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
News
Jun 2026
Knobbe Martens Practices, Partners Recognized for Standout IP Work in 2026 Chambers USA Guide
IRVINE, Calif., June 4, 2026 – Knobbe Martens is proud to share that numerous practices and partners across the firm are recommended for exceptional work in the 2026 Chambers USA...